Single-cell RNA sequencing (scRNA-seq) is a rich resource of cellular heterogeneity, opening new avenues in the study of complex tissues. We introduce Cell Population Mapping (CPM), a deconvolution algorithm in which reference scRNA-seq profiles are leveraged to infer the composition of cell types and states from bulk transcriptome data ('scBio' CRAN R-package).
S ingle-cell RNA sequencing (scRNA-seq) provides a powerful approach to understand the composition of different cell identities within a complex tissue, including discrete cell types, cell states that arise transiently during the progression of timedependent processes, and continuous dynamic transitions within the space of possible cell states 1, 2 . The frequency of cell types and cell states may vary between genetically distinct individuals, environments, chemical perturbations, and disease states. To investigate this variation at high resolution, it is possible to generate scRNAseq profiles for each sample of interest and then use it to evaluate the frequency of the different cell types and states [3] [4] [5] . However, such studies are costly and time-consuming, and have therefore been performed only on a limited scale.
An alternative strategy is to construct a comprehensive collection of reference scRNA-seq profiles representing various cell types and cell states. Deconvolution algorithms can then use the reference profiles to computationally predict the abundance of different cell types and states within a given sample, based on only the bulk expression data from that sample 2, [6] [7] [8] . This strategy should in principle avoid the scaling issues associated with multiple scRNA-seq experiments, but in practice, using a large number of reference profiles typically results in reduced prediction accuracy 9 . A standard solution is to cluster the single-cell reference profiles into a relatively small number of cell-group reference profiles [10] [11] [12] . However, although this clustering-based approach may provide a rough quantification of discrete cell types and states, the continuous cell-state space remains sparse and fragmented. Therefore, there is a substantial need for a deconvolution method that can exploit the rich spectrum of single-cell reference profiles.
Here we introduce the Cell Population Mapping (CPM) method, which provides an advantageous alternative to existing deconvolu-tion approaches, particularly in providing a fine-resolution mapping. Similarly to approaches described in recent studies [10] [11] [12] , CPM constructs its reference collection from scRNA-seq profiles derived from one or a few relevant samples, and then exploits this collection to infer cell composition within additional, bulk-profiled samples. However, instead of focusing on quantifying a few dozen discrete cell subtypes, CPM analyzes thousands of single-cell profiles scattered across the wide landscape of cell states. Using synthetic data, we demonstrate that deconvolution with CPM significantly improves the quantification of both gradual and abrupt changes in cell abundance over the continuous space of cell types and states. Furthermore, by analyzing complex changes in lung tissues, across influenza-virus-infected mice of various genetic backgrounds, we demonstrate the effectiveness of CPM in probing phenotypic diversity in large cohorts.
Results
Overview of CPM. We developed CPM, a method based on computational deconvolution for identifying a cell population map from bulk gene expression data of a heterogeneous sample. In our framework, the cell population map is the abundance of cells over a cell-state space. Cell type is defined as the core characteristics of a cell, whereas a cell state can be thought of as the current phenotype of a given cell type (for example, it can refer to the proliferation, activation, or differentiation state of the cell) 1 . The cell-state space specifies each cell state as a point in a multi-dimensional space; as cells undergo changes from one state to another, they travel through the space along a trajectory between these two states 13 . Unlike existing computational methods that focus on reconstruction of the cell-state space from scRNA-seq data 1 , CPM takes as its input the previously reconstructed cell-state space of certain scRNA-seq data,
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and then relies on this input to infer the abundance of each point in this space within a given bulk cell population.
Formally, CPM relies on two input types ( Fig. 1a ): first, a bulk expression profile of the heterogeneous cell population, and second, scRNA-seq profiles of individual single cells derived from one or a few representative samples ('reference data'). We assume that the cell-state space of the reference cells is given as input and that the particular position of each reference single cell within this space is known. The cell-state space is typically obtained by dimension reduction (such as t-SNE 14 ) that captures the essence of gene-regulation variation among the reference single cells (exemplified in Fig. 1b, top) . It is also possible to use a well-defined trajectory within this space as an alternative 'one-dimensional (1D) space'; such a trajectory can explicitly describe the progression of cells through a biological process ( Fig. 1b bottom) .
CPM consists of two steps ( Fig. 1a and Methods). The first step is application of a deconvolution approach (here, the support vector regression (SVR) approach) that combines the bulk profile of a complex tissue with a collection of reference scRNA-seq profiles to infer the composition of cells within the complex tissue input. The output of this step is the abundance of cells at the sub-region of each reference single cell. Such prediction poses two substantial challenges: accuracy in deconvolving a very large number of reference profiles (typically, the analysis may involve thousands of single cells 15 ), and a potential bias owing to the non-uniform distribution of reference cells over the cell-state space. To address these challenges, CPM applies deconvolution using a relatively small subset of reference profiles, which are obtained by unbiased random sampling to ensure that every region in the cell space has an equal chance of being sampled (Fig. 1c ). The sampling and deconvolution procedures are repeated N times (here, N = 1,500), and the results are aggregated and averaged into a single inferred abundance for each reference single cell. The second step is to extrapolate, from the inferred cell abundance in each particular reference coordinate, the cell abundance in any other cell-state coordinate (Fig. 1d ). In this extrapolation it is assumed that the shape of the cell distribution over the cell-state space is continuous and smooth. We refer to this smoothed continuous output as the 'cell population map' . Notably, CPM may use input bulk data either as a relative profile (that is, response between two samples) or as an absolute (singlesample) profile, thereby predicting relative or absolute cell-state abundance, respectively.
Performance analysis.
We used a simulation framework to measure the ability of CPM to predict the cell population map at fine resolution. The simulation was based on a collection of 1,860 reference scRNA-seq profiles 16 taken from murine lungs during influenza virus infection and encompassing nine major immune and non-immune cell types: fibroblasts, epithelial cells, blood and lymphatic endothelial cells, T cells, B cells, natural killer (NK) cells, granulocytes, and cells of the mononuclear phagocyte system (MPS), encompassing monocytes (MO), macrophages (MΦs), and dendritic cells. In this reference dataset, one well-characterized trajectory is the gradual transition of cell states (within each cell type) from resting (naive)-like cells into active cells that respond to the influenza virus infection 16 . We created synthetic bulk profiles of a complex tissue by mixing these single-cell profiles according to predetermined biologically relevant functions over the cell-state space, introducing noise in the expression of genes and in the coordinates of single cells (denoted 'expression noise' and 'cell space noise' , respectively). The quality of this strategy is demonstrated in Supplementary Fig. 1a and further discussed in Supplementary Note 1. CPM was compared to three alternative deconvolution methods-DCQ 17 , Cibersort 18 and standard SVR 19 -whose reference collection was the 'averaged' profiles of single-cell groups (the larger the number of such single-cell groups, the higher the 'granularity' analyzed by the alternative methods; Methods). We evaluated the 'accuracy' of predictions by comparing the groundtruth cell abundance to the predicted abundance of each reference single cell.
To analyze performance, we focused on three fundamental types of simulations: the 'cell-type simulation' , in which cell abundance varies from one cell type to another, but within each cell type, the abundance is uniformly distributed over the cell-state space; the 'cell-subtype simulation' , consisting of a modified abundance of a subpopulation of cell states within selected cell types; and the 'gradual-change simulation' , representing continuous alterations of cell abundance along the trajectory of cell-activation states (within 
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Step 2 selected cell types) ( Fig. 2a) . Overall, the cell-type simulation is focused on inter-cell-type variation, whereas the cell-subtype and gradual-change simulations are focused on intra-cell-type variation, which arises from differences among cell states within the same cell type.
Consistent with previous observations, changes in discrete cell types were accurately modeled by the alternative deconvolution methods ( Fig. 2b and Supplementary Fig. 1b ). However, in the case of intra-cell-type changes in the composition of cell states (the 'cellsubtype' and 'gradual-change' simulations), CPM showed consistent improvement in prediction accuracy compared to existing deconvolution methods (relative bulk data, Fig. 2c,d and Supplementary  Fig. 2a ,b; absolute bulk data, Supplementary Fig. 3a ,b) within a reasonable running time ( Supplementary Fig. 2c,d ). Unsurprisingly, CPM was able to capture the continuous nature of the input tissue, unlike alternative deconvolution methods, which could provide only a discrete approximation with lower accuracy (Supplementary Figs. 2e and 3c ). Furthermore, CPM outperformed the existing methods in its ability to handle a high cell-state complexity and in its 'scalability' to a large number of reference profiles ( Supplementary  Fig. 2f ,g and detailed in Supplementary Note 1). Quantitatively similar results were also observed for varying parameter settings ( Supplementary Fig. 4 ), using different cell-state space solutions ( Supplementary Fig. 5a ), and for regions of different local density within the cell-state space ( Supplementary Fig. 5b ,c). Of note, CPM may lose power with lower sequencing depth (Supplementary Fig. 6 and discussed in Supplementary Note 1).
Cell-state-specific relationships between infection symptoms and cell abundance.
We applied CPM to investigate in vivo influenza virus infection across the Collaborative Cross (CC) recombinant inbred strains 20 , a panel of mouse lines designed to mimic the phenotypic and genotypic diversity seen in human populations. To this end, we generated bulk transcriptional expression profiles derived from lung tissues of 38 infected and 34 phosphate-buffered saline (PBS)-treated control mice (typically one or two individuals of each CC strain; Supplementary Table 1 and Methods). We transformed absolute bulk profiles into relative bulk profiles using a common control profile as the normalizer, and then applied CPM to each of these bulk profiles using the aforementioned single-cell measurements of the same experimental setting (lung tissues from influenza-virus-infected mice 16 ) as the reference data. As the cellstate space, CPM used the continuous sequence of cell-activation states that were previously defined for each of the nine immune and non-immune cell types in this reference dataset 16 . Altogether, CPM calculated a relative cell population map consisting of relative cell abundance in each cell state for each individual mouse. We found that CPM predictions varied considerably between individuals (see Accuracy is defined as the Pearson correlation coefficient between predicted and true cell abundance and is shown across varying data parameters, such as the level of inaccuracy ("noise") that was synthetically generated (x axis) for alternative deconvolution methods. Results are shown for bulk relative profiles (b (left), c, and d) or absolute profiles (b, right). The alternative methods were applied with a reference dataset that was generated using granularity of four cell groups. examples in Fig. 3a ) and that this variation was robust across the N deconvolution repeats ( Supplementary Fig. 7a ).
Although the inferred cell population maps demonstrated substantial variation, the extent to which these cell-state changes related to the clinical outcome of disease remained unclear. To elucidate this point, we monitored one of the main clinical symptoms of murine infection, namely, body weight loss (measured at 2 d post-infection (p.i.); Fig. 3b ), and calculated the correlation (across individuals) between this outcome and the inferred relative abundance of each reference cell (denoted the 'cell-to-phenotype correlation'). By splitting the reference cells into consecutive activation-state intervals (within each cell type), we could assess the variation in cell-to-phenotype correlations over the activation trajectory (illustrated in Supplementary Fig. 7b ). Intriguingly, cellto-phenotype correlations across infected mice clearly showed a gradual increase over the trajectory of cell-activation states, from negative correlations at the lower (naive-like) range to positive correlations at the upper (activated) range (mainly in T cells, MPS, and fibroblasts; Fig. 3c ). In fact, no particular threshold could be found that split the activation-state trajectory into two discrete groups in which cell-to-phenotype correlations did not gradually change. Similar conclusions about the gradual change in cell-to-phenotype correlations were obtained using a second public dataset of influenza virus infection 21 and using additional computational analyses (Supplementary Note 1 and Supplementary Fig. 7c -h). As expected, the use of unrelated (uninfected) reference datasets and alternative deconvolution methods did not yield the same conclusions (Supplementary Note 1 and Supplementary Fig. 7i ,j). Taken together, these findings highlight the advantage of a CPM model that is based on a continuous space of cell states, and further emphasize the importance of using reference and bulk data derived from a similar experimental setting.
Experimental validation of predictions.
To test for the presence of a gradual change in cell-to-phenotype relationships as predicted by CPM, we performed flow cytometry analyses of lung cells from influenza-infected CC mice at 2 d p.i. We focused on MO/MΦ cell types, which constitute a major fraction of the total MPS population. To determine the activation states of MO/MΦs, we used flow cytometry with two established cell-activation markers, CD64 and Ly6C 22 . The use of these markers enabled us to quantify the distribution of cells over a trajectory of activation states ranging from noninflammatory (CD64 low Ly6C low ) to inflammatory (CD64 high Ly6C high ) MO/MΦs. As expected, the fraction of inflammatory MO/MΦs was higher in infected mice than in PBS-treated controls (Fig. 4a,b and Supplementary Table 1 ). Encouraged by this observation, we used the flow cytometry measurements to calculate the cell-to-phenotype correlation, that is, the correlation between the clinical readout (weight loss at 2 d p.i.) and the MO/MΦ cell fractions enumerated by flow cytometry across infected individuals. The correlation analysis yielded several lines of evidence that validated the reconstruction by CPM: inflammatory MO/MΦs showed a positive cell-to-phenotype correlation (r 2 = 0.67, Fig. 4c left) ; non-inflammatory MO/MΦs had a negative cell-to-phenotype correlation (r 2 = −0.54; Fig. 4c , right); cell-to-phenotype correlations increased with each of the two separate activation markers (Fig. 4d ); and flow cytometry analysis confirmed a gradual increase in correlation values over the CD64cell-state continuum for both Ly6C high and Ly6C low cell states (Fig. 4e ). The lack of cell-to-phenotype correlation obtained when we used the total MO/MΦs count (r 2 = 0.1; Supplementary Fig. 8a ) further validated the contention that cell-to-phenotype relationships depend on particular cell-activation states, thus accentuating the importance of fine-resolution deconvolution mapping. The observed association between activated inflammatory MO/MΦs and severe physiological responses ( Fig. 4c , left) has been reported previously [23] [24] [25] , whereas the opposite trend of naive MO/MΦs (Fig. 4c , right) and the continuous transition between negative and positive correlations over the activation process ( Fig. 4e ) have not been described previously.
Inferring dynamics with a Markov model. Given that the CPMreconstructed map yielded accurate predictions for MPS cells, we next investigated the temporal dynamics over the activation trajectory for these cells. Our results showed that the association between cell abundance and weight loss varied in a gradual manner along the MPS-activation process (Figs. 3c and 4e), but that the total MPS counts did not correlate with body weight loss ( Supplementary  Fig. 8a) . A parsimonious explanation for this observation is that the phenotypic diversity is associated with inter-individual variation in temporal dynamics along the activation process; for example, inter-individual variation in onset times, or in cell-state progression rates. Like scRNA-seq data 26 , the CPM-reconstructed data provided valuable information that allowed such temporal dynamics to be computationally reconstructed. For instance, we focused here on cell-state progression, and because its underlying mechanism is a stochastic process, we assumed a Markov process of naive-to-activation transitions between consecutive cell states ( Supplementary  Fig. 8b and Methods). We used this model to predict the probability of transition ('transition rate') between sequential states in each individual mouse (see examples in Supplementary Fig. 8c ). With the assumption that the activation-onset time in all individuals is the same, comparison of the inferred transition rates might reveal complex transition-rate-to-phenotype relationships ( Supplementary  Fig. 8d ). By calculating transition rates based on CPM predictions, we found that weight loss was indeed positively correlated with transition rates over a wide range of the MPS activation axis (at its early and intermediate parts; Supplementary Fig. 8e ). These CPMpredicted transition rates closely matched the rates calculated from flow cytometry measurements ( Supplementary Fig. 8e,f) . Overall, this theoretical approach suggests a mechanistic model of in vivo influenza-outcome diversity and demonstrates a general strategy for uncovering inter-individual variation in temporal dynamics.
Discussion
CPM enables the reconstruction of cellular heterogeneity at fine resolution in many bulk-profiled samples, relying on reference singlecell data from only one or a few representative samples (Fig. 1 ). We attribute the success of CPM to two main advantages. First, the resolution of cell states enables the identification of alterations that are otherwise impossible to detect. Second, CPM's continuous cell-state mapping is well suited for biological scenarios in which the underlying mechanisms drive continuous transitions between cell types or states (for example, a differentiation/developmental continuum, or temporal dynamics during fast response to environmental stimuli). Indeed, we have demonstrated how the association between disease severity and cell-state dynamics provides new insights into the progression of infection. We believe that the basic framework of CPM will spur the development of additional methods and will prove useful for additional analyses. First, CPM infers the quantities of cell states, a prerequisite for additional studies such as calculations of cell-state-specific expression within complex tissues 27 and reconstruction of temporal dynamics of cell-state progression. Second, an exciting extension of CPM would be the development of a 'functioning tissue' model through integration of cell states together with their spatial organization. To address this, CPM would require significant extension by incorporating the 3D organization as another factor of the cellular state. This is a difficult task because a given spatial location may include different cell types and states. Third, although CPM outperforms existing methods, we expect that additional extensions would enable improved performance (for example, using multiple splicing isoforms rather than the canonical isoform of each gene). Finally, CPM provides a framework to study cellular heterogeneity within the massive body of existing bulk genomics data such as in TCGA 28 and GTeX 29 . As extensive single-cell catalogues (for example, the Human Cell Atlas 30 ) are currently in construction, it may soon become possible to analyze cellular heterogeneity in bulk expression data without requiring expertise in single-cell technologies (discussed in Supplementary Note 1).
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Methods
The CPM algorithm. CPM takes as input both bulk transcriptome and reference data. The input bulk transcriptome is represented in a column vector of expression values across all genes. Bulk expression values can be either the measured expression values in a single heterogeneous tissue or the relative values between two experiments, such as diseased versus healthy heterogeneous tissues. The input reference data consist of scRNA-seq profiles, represented in a matrix of the format R ij , where the ijth entry is the expression level of gene j in single cell i. A row vector R i in this matrix is an RNA-seq signature of a certain reference single cell i (referred to as a 'reference profile'). We further assume that the main split of cells into broad cell-type categories is known, and that low-quality cells were already removed 16 . In addition, we assume that each cell type is associated with a predetermined neighborhood structure, denoted the 'cell-state space' structure. The cell-state space is represented as a set of coordinates, where the ith entry represents the position of reference single cell i within the cell-state space. The cell space should be constructed in a pre-processing step through various single-cell analysis techniques. For instance, it is possible to exploit standard dimension reduction methods that provide cell positions in a low-dimensionality space (such as t-SNE or using several principal components 14 ). Alternatively, it is possible to determine the position of cells along a certain trajectory of cell states and use this trajectory as a one-dimensional cell-state space 14 .
CPM starts with a preprocessing step in which genes carrying many dropout events (here, fraction of zero expression values across single cells >90%) are filtered. Both the reference profiles and the input bulk profile are then standardized. Next, the algorithm proceeds in two steps: first, the composition of reference cells within the complex tissue is inferred, and then this information is used to predict cell abundance over the entire continuous cell-state space.
Step 1 (deconvolution). To infer the abundance level of the reference cells in a bulk expression profile, we solve the following linear regression:
where R i is the expression vector of all genes in reference single cell i, U is the vector of expression levels of all genes in the complex tissue, and β i indicates the unknown abundance of single cell i in the complex tissue. As in Cibersort 18 , we achieve robustness by solving this regression using linear SVR (the 'LiblineaR' v2.10-8 R package 19 ) to prevent biases due to outliers. To further improve performance in the presence of a large number of reference profiles, we use a consensus approach in which the aforementioned SVR inference is repeated N times for N different subsets of the reference profiles (denoted 'reference subsets'), each reference subset consisting of Ns profiles. Predicted abundance values of the N runs are then averaged for each individual reference cell.
We apply several improvements that make step 1 more robust and accurate. First, we perform an unbiased random selection of the reference subset (without replacements) so that the selected subset is distributed uniformly over the cell-state space. To address this, each reference cell is sampled by random sampling of a 'pivot point' within the cell-state space using inverse transform sampling and then choosing an arbitrary reference cell in the proximity of this pivot point. A grid was added to the cell-state space so that all reference cells that fall in a certain entry of this grid are defined as the proximity group for a pivot that falls in this entry. The number of grid entries, calculated on each cell type separately, is the number of reference single cells divided by the cell neighborhood size. N was set to a value at which each reference cell would be selected to an average depth of at least Nr repeats. In particular, given that cells in high-density grid entries are less likely to be selected, we calculate N based on the highest density entry by requiring that each cell in this entry would be selected to an average depth of Nr repeats.
The second improvement is that each SVR run is applied to a set of genes that is tailored for a specific reference subset. The basic idea is to select a gene set that offers the best ability to distinguish between the reference profiles. Similarly to Cibersort 18 , for each gene we compare its expression in different scRNA-seq profiles using one-way ANOVA (the Nd nearest neighbors of each cell are used to calculate the within-group variance component); each gene is then associated with the cell profile in which it attains the highest average expression, and the Ng top ANOVA-score genes associated with each cell profile are selected. In particular, Ng is defined as the number that minimizes the 'condition number' that is calculated with the R 'kappa' function.
Step 2 (extrapolation). To infer the abundance of a given candidate cell state, CPM averages the predicted abundances of its Nd nearest-neighbor reference cells. This leads to a smoothed cell abundance over the entire cell-state space. We refer to this solution as the 'cell population map' .
Overall, the methodology relies on three parameters: the number of deconvolution repeats (determined by Nr), the reference subset size (Ns) and the cell neighborhood size (Nd). Here we used Nr = 5, Ns = 50, and Nd = 10 as our default setting. The contribution of CPM is further discussed in Supplementary Note 1.
The reference single-cell data. The reference data are a collection of 1,860 single cells that were collected from the lungs of a C57BL/6 mouse 2 d after infection with 4.8 × 10 3 plaque-forming units (pfu) (in 40 µl of PBS) of the PR8 influenza virus (published data 16 from GEO accession number GSE107947). As reported previously 16 , this collection already excludes poor-quality cells, and the cells were already partitioned into nine cell-type groups (in total, 92 B cells, 135 blood endothelial cells, 24 epithelial cells, 291 granulocytes (GN), 345 lymphatic endothelial cells, 375 fibroblasts, 103 mononuclear phagocyte system (MPS) cells, 117 NK cells, and 378 T cells). Furthermore, the progression of cell states through a trajectory of an antiviral-activation response was previously defined for each of the nine immune and non-immune cell types 16 . We refer to this continuum as the 'trajectory' of cell-activation states. In brief, the cell-state trajectory was constructed in two steps: first, a group of 101 generic-response genes were defined (consisting of all genes that were upregulated in all nine cell types during influenza infection); next, for each single cell, its average expression level across these generic genes was used as the activation-state trajectory 16 (in Figs. 3a,c and 4d,e and Supplementary Fig. 7c -g,i,j, this trajectory was further binned into equal intervals). Unless stated otherwise, this reference single-cell collection, together with its cell type groups and cell-state trajectory, were used as input in our analyses. We note that scRNA-seq data from a replicate infected mouse 16 was used to corroborate the results ( Supplementary Fig. 7f ).
Synthetic data analysis.
Synthetic bulk profiles were generated by mimicking the heterogeneity of cells within a biological complex tissue. Each synthetic bulk profile was generated as a mixture of reference scRNA-seq profiles according to pre-designed fractions of single cells. Our pre-designed fractions of cells represent prevalent realistic scenarios, including changes in the overall level of a certain subpopulation (the cell-type and cell-subtype simulations), as well as changes along cellular trajectories such as cell-state shifts (the gradual-change simulation). We generated both absolute and relative synthetic bulk profiles and in both cases tested the entire range of the noise parameter (ranging from entirely non-informative data to almost-zero noise). The 'accuracy' was calculated as the Pearson correlation between the actual and predicted fractions of cells. Technical details of synthetic data generation and the accuracy score are available in Supplementary Note 1.
For each synthetic data collection, the performance of CPM was compared to alternative state-of-the-art deconvolution algorithms, including the digital cell quantifier (DCQ) algorithm 17 , which builds on elastic net regression; Cibersort 18 , which utilizes a non-iterative linear support vector regression; and a standard linear SVR. SVR was applied using L2-regularized L2-loss support (primal) vector regression because it provided similar accuracy compared to alternative settings but is faster than the alternatives. SVR was applied with the optimal setting of its C (the 'LiblineaR' R package 19 ) and ε = 0.001 (all results were maintained with alternative ε values such as 0.1 and 0.001; Supplementary Fig. 2h ). Using SVR and Cibersort, in the case of relative data we retained the negative coefficients, as previously suggested 17 . For the CPM algorithm, we further tested the effect of modifying the Nr, Ns, and Nd parameters. As the three compared deconvolution methods rely on a relatively small number of input reference profiles, the reference data were constructed by grouping of the scRNA-seq profiles. We used K-means clustering of the scRNA-seq data 16 and then used the averaged profile of each group as a reference profile. Supplementary Note 1 further describes alternative reference-construction methods whose accuracy levels are presented in Supplementary Fig. 4e . Each of the compared methods was analyzed using a variety of K (granularity) values. Finally, we compared CPM to an alternative approach in which cell composition is evaluated through enrichment of each individual reference profile (an 'enrichment scheme' , as described previously 31 ; detailed in Supplementary Note 1).
To verify that the mixture of single cells fully resembles real-data bulk profiles, we generated synthetic bulk expression values as a mixture of scRNA-seq of an uninfected C57BL/6J mouse (2,075 cells derived from the lung tissue, partitioned into nine cell types 16 ), using quantities that were measured previously within the lungs of naive C57BL/6J mice (flow cytometry fractions from previous studies 22, 32 ). We further measured bulk lung profiles of a naive C57BL/6J mouse (Supplementary Table 1 ) and found a good match between measured and computationally synthesized bulk data ( Supplementary Fig. 1a ), supporting the validity of aggregating single cells into synthetic bulk profiles.
Mice. The present study used female mice aged 7-10 weeks from the Tel Aviv University (TAU) collection of Collaborative Cross recombinant inbred mice 20 and the C57BL/6J strain. The mice were raised at the Animal Facility at the Sackler Faculty of Medicine of TAU. All experimental mice and protocols were approved by the Institutional Animal Care and Use Committee (IACUC) of TAU (approval number 04-14-049), which adheres to Israeli guidelines and follows the US NIH animal care and use protocols. Mice were housed on hardwood chip bedding under a 12 h light/dark cycle at 21-23 °C. Mice were given tap water and standard rodent chow diet ad libitum from their weaning day until the end of the experiment.
In vivo influenza virus infection.
Mouse-adapted PR8 strain, influenza virus A/Puerto Rico/8/34 (A/PR/8/34, H1N1), was persistently grown in hen egg amnion, and its effective titer was quantified. All mice were anesthetized with 7 mg ml -1 ketamine and 1.4 mg ml -1 xylazine at 0.1 ml per 10 g body weight, intraperitoneally. Animals were then infected intranasally with PR8 (4.8 × 10 3 pfu in 40 µl PBS), whereas mock-treated ('control') animals received only 40 µl PBS. All mice were monitored daily for percentage body weight loss and clinical disease manifestations, and euthanized at 48 h post treatment. Of note, this experimental setting closely resembles that of the reference scRNA-seq data 16 (for example, the same gender, time after infection and virus strain, similar age and virus doses).
RNA isolation, library construction and pre-processing.
To test CPM on complex tissues, murine lungs were collected immediately after mice were killed, sliced into small pieces, homogenized using a D1030-E BeadBlaster Microtube Homogenizer (Benchmark Scientific; 90 s, 4,000 r.p.m.) in the presence of QIAzol, and used for total RNA extraction using the miRNeasy Mini Kit (Qiagen). Library quality and concentration was measured using a TapeStation System (Agilent Technologies) and a Qubit Fluorometric Quantitation (Life Technologies), as described earlier 17 . mRNA sequencing libraries were constructed as described previously 17 . Absolute bulk profiles were generated through read alignment and transcript quantification, as described earlier 17 (detailed in Supplementary Note 1) . Absolute profiles were transformed into 'relative' profiles using a common control profile as the normalizer, where the control profile was pooled from the PBStreated mice. Relative profiles were calculated using log-transformed infected and control samples. Unless stated otherwise, results reported are the results of using relative profiles.
Cell-to-phenotype correlations. CPM was applied on each bulk RNA-seq lung sample by integrating the reference single cell collection (a total running time of ~16 min for deconvolution of 72 samples, using six cores of a Dell Latitude E6430 laptop, containing an Intel i7-3740QM CPU). Our analysis builds on the CPMinferred abundance of each reference single cell in each individual mouse. For each reference cell (associated with a particular cell-activation state) we calculated the 'cell-to-phenotype correlation' as a Pearson correlation coefficient between the predicted abundance of cells at this cell state and the in vivo clinical phenotype at 2 d p.i. (illustrated in Supplementary Fig. 7b ). The cell-to-phenotype correlation was calculated using two groups of mice: either the infected or the control (PBStreated) mice. Cell-to-phenotype correlations were binned into nine equal intervals along the trajectory of cell activation states. Supplementary Note 1 describes several tests that were applied to support the inferred gradual changes over the cellactivation bins.
Fluorescence-activated cell sorting and analysis.
To validate the performance of CPM, we sorted the population of macrophages from the lungs of various CC mice ( Supplementary Table 1 ). To address this, the lungs were dissociated into single-cell suspensions using a Miltenyi Biotec lung dissociation kit (130-095-927) and gentleMACS dissociator (Miltenyi Biotec) , according to the manufacturer's instructions. Isolated lung cells were then enriched for CD45 + cells by positive selection (CD45 microbeads, Miltenyi Biotec, 130-052-301), incubated with blocking solution (5% normal mouse serum, 5% normal rat serum, and 1% antimouse CD16/CD32) for 30 min on ice, and stained with fluorochrome-conjugated antibody for CD11b (M1/70), CD64 (X54-5/7.1), I-A/I-E (M5/114.15.2), Ly6G (1A8), Ly6C (HK1.4), and CD45 (30-F11, Miltenyi Biotec). All antibodies were from Biolegend, unless otherwise mentioned (clone number in parentheses). Data were obtained using a SH800 flow cytometer (Sony Biotechnology) and analyzed with FlowJo v.10 software. Mononuclear phagocyte cells were gated as CD11b + CD45 + Ly6G -I-A/I-E + , as described previously 22 , and the expression levels of Ly6C and CD64 were analyzed.
Inferring dynamics with a Markov model. In this analysis, we rely on the assumption that cells along the activation trajectory are partitioned into D equal intervals. The ith interval represents a discrete cell state i. In addition, we assume that the probability of transition between any two states (per unit time) is constant over time. The 'stochastic matrix' Q DxD encodes the probabilities of transitions q ij from state i to state j per unit time (referred to as 'transition rates'). Assuming that each cell in each state i may remain in the same state or switch into state i + 1 (but not to any other cell state), it follows that for each i, q ii + q i,i+1 = 1; and for each ∉ + j i i { , 1}, q ij = 0. We further define a row vector F 1xD = (f 1 , f 2 ,…, f D ), where f i is the proportion of cells in state i (denoted a 'state proportions vector'). We assume that each cell resides in exactly one of the cell states, and therefore ∑ = = ... f 1
The state proportions vector before infection and at any time t after infection are F (0) and F (t) , respectively. Q t encodes the probability of transitions after t units of time, and therefore F (t) = F (0) Q t . Using known state proportions vectors F (0) and F (t) (either CPM-inferred or FACS-measured; Supplementary Fig. 8e,f, For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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The bulk RNA-seq datasets has been deposited in the Gene Expression Omnibus (GEO) database, under GEO accession numbers GSE113530 and GSE117975.
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Sample size 80 female mice from 20 different lines of new developed Collaborative Cross and one C57BL/6J mouse were used for sequencing. Our analysis with 20 CC lines in Nachshon et al. 2016 (Frontiers in genetics, DOI: 10.3389/fgene.2016.00172) show that 20 lines should be sufficient to provide informative associations. We also used 13 mice from 6 CC lines for FACS validation; this number were chosen since CPM-inferred cellto-phenotype correlations can be already observed with 13 mice.
Data exclusions None
Replication Not relevant, since our mice had a large variety of genetic backgrounds. However we did noticed that the gene expression profiles of mice from the same strain was usually more similar than the gene expression profiles of mice from different strains.
Randomization Allocation of mice from each CC strain into the infected, PBS-control and untreated groups was random.
Blinding
Investigators were not blinded to group allocation. However, the main data contained a set of comprehensive gene expression profiles (with more than 20000 genes). We used the same method on each one of these full profiles and analyzed the results. We could not influence the results since initially we did not know the prediction for the samples. In the FACS analysis we mostly compared mice within each group and not between them.
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